NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Safety Study of Combination of Hormone Therapy, Paclitaxel and Radiation Therapy to Treat Prostate Cancer

Phase 1

Completed

Conditions: Prostate Cancer

Interventions: Drug: Hormone Suppressors
Drug: Paclitaxel
Radiation: Radiation Therapy

First Posted Date: 2016-09-22

Last Posted Date: 2017-10-02

Lead Sponsor: NYU Langone Health

Target Recruit Count: 23

Registration Number: NCT02911350

Study of Irinotecan and AZD1775, a Selective Wee 1 Inhibitor, in RAS or BRAF Mutated, Second-line Metastatic Colorectal Cancer

Phase 1

Completed

Conditions: Metastatic Colorectal Cancer

Interventions: Drug: AZD1775
Drug: Irinotecan

First Posted Date: 2016-09-19

Last Posted Date: 2020-10-12

Lead Sponsor: NYU Langone Health

Target Recruit Count: 7

Registration Number: NCT02906059

Locations: 🇺🇸
Laura and Isaac Perlmutter Cancer Center, New York, New York, United States

Heart Attack Research Program- Imaging Study

Recruiting

Conditions: Myocardial Infarction

Interventions: Device: OCT
Other: CMR

First Posted Date: 2016-09-19

Last Posted Date: 2025-04-30

Lead Sponsor: NYU Langone Health

Target Recruit Count: 450

Registration Number: NCT02905357

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
Stanford University, Stanford, California, United States
🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States

and more 16 locations

Presurgical Trial of Denosumab in Breast Cancer

Early Phase 1

Completed

Conditions: Breast Cancer

Interventions: Biological: denosumab
Procedure: Surgery

First Posted Date: 2016-09-14

Last Posted Date: 2020-08-21

Lead Sponsor: NYU Langone Health

Target Recruit Count: 44

Registration Number: NCT02900469

Locations: 🇺🇸
NYU Perlmutter Cancer Center, New York, New York, United States

Music Workshops in the EMPOWER Clinic

Not Applicable

Withdrawn

Conditions: Trauma
Sexual Violence
Sex Trafficking

Interventions: Behavioral: Music Workshop

First Posted Date: 2016-09-13

Last Posted Date: 2019-04-05

Lead Sponsor: NYU Langone Health

Registration Number: NCT02897505

Stress Reduction Intervention for Women With Ischemic Heart Disease

Not Applicable

Terminated

Conditions: Ischemic Heart Disease

Interventions: Behavioral: Early SR intervention
Behavioral: Delayed SR intervention

First Posted Date: 2016-09-08

Last Posted Date: 2018-07-19

Lead Sponsor: NYU Langone Health

Target Recruit Count: 6

Registration Number: NCT02893579

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Leveraging Technology to Address Unhealthy Drug Use in Primary Care Settings

Not Applicable

Completed

Conditions: Addiction

Interventions: Other: Screening Only (SO) condition
Other: SUSIT Condition

First Posted Date: 2016-09-08

Last Posted Date: 2022-05-09

Lead Sponsor: NYU Langone Health

Target Recruit Count: 79

Registration Number: NCT02893514

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Imaging Biomarkers of Knee Osteoarthritis

Not Applicable

Completed

Conditions: Osteoarthritis

Interventions: Device: PRISMA 3T MRI scanner (Siemens Medical Solutions)

First Posted Date: 2016-09-02

Last Posted Date: 2022-12-27

Lead Sponsor: NYU Langone Health

Target Recruit Count: 50

Registration Number: NCT02888119

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Food as Medicine: An RCT to Study the Effect of Home Delivered, Medically Tailored Meals on Patients With Metastatic Cancer

Not Applicable

Completed

Conditions: Quality of Life

Interventions: Other: Home Delivered, Medically Tailored Meals (HDTM)

First Posted Date: 2016-09-02

Last Posted Date: 2020-06-09

Lead Sponsor: NYU Langone Health

Target Recruit Count: 6

Registration Number: NCT02887235

Locations: 🇺🇸
NYU Perlmutter Cancer Center, New York, New York, United States

Safety Study of the Hypo-fractionated (Large Doses) Radiation Therapy in Post-menopausal Women With Breast Cancers

Phase 1

Completed

Conditions: Breast Cancer

Interventions: Radiation: 6 Gy/ fraction

First Posted Date: 2016-08-30

Last Posted Date: 2018-12-21

Lead Sponsor: NYU Langone Health

Target Recruit Count: 100

Registration Number: NCT02883985

Locations: 🇺🇸
NYU Perlmutter Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy